How much are we spending? The estimation of research expenditures on cardiovascular disease in Canada

Abstract

BackgroundCardiovascular disease (CVD) is a leading cause of death in Canada and is a priority area for medical research. The research funding landscape in Canada has changed quite a bit over the last few decades, as have funding levels. Our objective was to estimate the magnitude of expenditures on CVD research for the public and charitable (not-for profit) sectors in Canada between 1975 and 2005.MethodsTo estimate research expenditures for the public and charitable sectors, we compiled a complete list of granting agencies in Canada, contacted each agency and the Canadian Institutes of Health Research (CIHR), and extracted data from the organizations’ annual reports and the Reference Lists of health research in Canada. Two independent reviewers scanned all grant and fellowship/scholarship titles (and summary/key words, when available) of all research projects funded to determine their inclusion in our analysis; only grants and fellowships/scholarships that focused on heart and peripheral vascular diseases were selected.ResultsPublic/charitable sector funding increased 7.5 times, from close to $13 million (in constant dollars) in 1975 to almost $96 million (in constant dollars) in 2005 (base year). The Medical Research Council of Canada (MRCC)/CIHR and the Heart & Stroke Foundation of Canada have been the main founders of this type of research during our analysis period; the Alberta Heritage Foundation for Medical Research and the Fonds de la recherche en santé du Quebec have played major roles at the provincial level. The Indirect Costs Research Program and Canada Foundation for Innovation have played major roles in terms of funding in the last years of our analysis.ConclusionPublic/charitable-funded research expenditures devoted to CVD have increased substantially over the last three decades. By international standards, the evidence suggests Canada spends less on health-related research than the UK and the US, at least in absolute terms. However, this may not be too problematic as Canada is likely to free-ride from research undertaken elsewhere. Understanding these past trends in research funding may provide decision makers with important information for planning future research efforts. Future work in this area should include the use of our coding methods to obtain estimates of funded research for other diseases in Canada.

Postprandial lipoprotein profile in two modes of high-intensity intermittent exercise

“…Indeed, triacylglycerol have been associated to 13% and 12% more odds of cardiovascular diseases and all-cause mortality, respectively (Liu et al, 2013). In addition, cardiovascular disease has a significant public health cost (Azambuja et al, 2008; de Oliveira et al, 2012). …”

Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis

“…We have previously published on public and charitable research expenditures in Canada. 8 Briefly, we compiled a list of all major public-and charitable-sector granting agencies and organizations in Canada that fund cardiovascular research (Box 1); we then contacted each organization to obtain expenditures related to cardiovascular disease research from 1975 to 2005. Information was provided directly by the organization, obtained from its annual reports or the reference lists of health research in Canada (which include data on grants and awards collected by the former Medical Research Council of Canada).…”

Developing a database for Rett syndrome research performed in the European Union: A resource for researchers and stakeholders

“…This trend in member states of the EU is shaped by the EU research support system and the presence of numerous and diverse funders. According to a widely used classification, research funding of rare diseases comes from three major sources: public sector funding and nonprofit and for‐profit funding of the private sector (de Oliveira et al ). Public sector funding is raised through taxation (Directory of Social Change, ), which includes bodies operating at government departments, local authorities, and nondepartmental public bodies.…”